Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical Outcome
- 1 December 2019
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 3 (3) , 1-12
Abstract
PURPOSETo compare the prevalence of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castrate-resistant prostate cancer (mCRPC) and assess the impact of mut...Keywords
This publication has 54 references indexed in Scilit:
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approachesOncogene, 2013
- Germline Predictors of Androgen Deprivation Therapy Response in Advanced Prostate CancerMayo Clinic Proceedings, 2012
- Obesity is associated with castration‐resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH databaseBJU International, 2011
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisBritish Journal of Cancer, 2010
- New Developments in the Medical Management of Prostate CancerMayo Clinic Proceedings, 2010
- Molecular mechanisms of metastasis in prostate cancerAsian Journal of Andrology, 2008
- FANCM and FAAP24 Function in ATR-Mediated Checkpoint Signaling Independently of the Fanconi Anemia Core ComplexMolecular Cell, 2008
- LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARSJournal of Urology, 2000
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999